Page last updated: 2024-10-26

dipropizine and Sarcoidosis

dipropizine has been researched along with Sarcoidosis in 1 studies

Sarcoidosis: An idiopathic systemic inflammatory granulomatous disorder comprised of epithelioid and multinucleated giant cells with little necrosis. It usually invades the lungs with fibrosis and may also involve lymph nodes, skin, liver, spleen, eyes, phalangeal bones, and parotid glands.

Research Excerpts

ExcerptRelevanceReference
" Levodropropizine dosage was 60 mg t."1.28[Efficacy and safety of the use of levodropropizine in patients with chronic interstitial lung diseases]. ( Gunella, G; Massimo Vanasia, CB; Zanasi, A, 1991)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gunella, G1
Zanasi, A1
Massimo Vanasia, CB1

Other Studies

1 other study available for dipropizine and Sarcoidosis

ArticleYear
[Efficacy and safety of the use of levodropropizine in patients with chronic interstitial lung diseases].
    La Clinica terapeutica, 1991, Feb-28, Volume: 136, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antitussive Agents; Drug Evaluation; Drug Tolerance; Female; Humans;

1991